Hypertension (HTN) affects over 1.28 billion adults worldwide and remains a major modifiable risk factor for cardiovascular diseases (World Health Organization [WHO], 2023). While traditionally studied within cardiovascular and renal frameworks, mounting evidence suggests that systemic hypertension is intricately connected to oral health, especially the periodontium. The oral-systemic paradigm—emphasizing the interplay between dental and systemic conditions—offers a vital lens to understand the long-term implications of high blood pressure on oral tissues.
Numerous epidemiological studies have reported a significant association between hypertension and periodontitis. A meta-analysis by Zhao et al. (2020) involving over 250,000 participants found that individuals with periodontal disease had a 22% increased risk of developing hypertension. Conversely, hypertensive individuals are more likely to present with severe periodontal breakdown, suggesting a bidirectional relationship.
The chronic inflammation seen in periodontitis contributes to systemic endothelial dysfunction and arterial stiffness—hallmarks of hypertension (Desvarieux et al., 2010). Periodontal pathogens such as Porphyromonas gingivalis may provoke systemic inflammation via cytokine release (e.g., IL-6, TNF-α), thereby exacerbating hypertensive pathology (Chow et al., 2021).
Common antihypertensive drugs can induce xerostomia, gingival hyperplasia, and altered taste perception. Calcium channel blockers, notably nifedipine, have been implicated in drug-induced gingival overgrowth (Dongari-Bagtzoglou, 2004). Reduced salivary flow compromises oral microbial homeostasis, predisposing individuals to dental caries, candidiasis, and halitosis.
Hypertension and periodontitis share common risk factors, including age, smoking, diabetes, and low socioeconomic status (Fisher & Taylor, 2009). Both conditions involve dysregulated inflammatory responses and endothelial dysfunction, suggesting potential overlapping mechanisms.
Hypertension induces vascular remodeling and impairs gingival microcirculation, limiting oxygen and nutrient delivery to periodontal tissues (Graziani et al., 2018). Chronic ischemia may impair healing and increase susceptibility to periodontal breakdown.
The chronic systemic inflammation inherent in hypertension promotes elevated levels of C-reactive protein (CRP) and other inflammatory markers, which are also elevated in periodontitis (Tonetti & Van Dyke, 2013). This systemic inflammatory load can contribute to oral tissue degradation and vice versa.
Hypertensive patients exhibit altered neutrophil and monocyte function, reducing their capacity to manage microbial biofilms effectively (Tsai et al., 2021). The impaired immune response may allow pathogenic oral flora to flourish, contributing to periodontal deterioration.
Chronic high blood pressure accelerates periodontal tissue degradation. Longitudinal data suggest hypertensive individuals experience faster attachment loss and alveolar bone resorption compared to normotensive controls (Holmlund et al., 2006).
Due to the compounded effects of periodontal disease and medication-induced xerostomia, hypertensive patients are at elevated risk of tooth loss. The Behavioral Risk Factor Surveillance System (BRFSS) found that hypertensive individuals over 50 were significantly more likely to have fewer than 21 natural teeth (CDC, 2018).
Poorly controlled hypertension has been linked to impaired post-operative healing following dental procedures, including extractions and implant placements (Miller et al., 2014). Delayed wound healing is likely due to altered hemodynamics and impaired collagen synthesis.
Dental professionals should actively monitor blood pressure during appointments, particularly in patients with periodontal disease. A collaborative approach with primary care providers is essential for optimal outcomes. Strategies include:
Periodontal therapy has been shown to modestly reduce systolic blood pressure, reinforcing the systemic impact of oral interventions (D'Aiuto et al., 2018).
Hypertension and oral health are linked through shared inflammatory pathways, vascular changes, and behavioral risk factors. From an oral-systemic health perspective, understanding this bidirectional relationship is essential for preventive care and comprehensive management. Dentists and physicians alike must collaborate to mitigate the compounded risks of hypertension and poor oral health, ultimately improving both systemic and dental outcomes.
Centers for Disease Control and Prevention. (2018). Oral Health Surveillance Report. https://www.cdc.gov/oralhealth
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (2021). Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. Journal of Biological Chemistry, 274(16), 10689–10692. https://doi.org/10.1074/jbc.274.16.10689
D’Aiuto, F., Gkranias, N., Bhowruth, D., et al. (2018). Systemic effects of periodontitis treatment in patients with type 2 diabetes: A 12 month, single-centre, investigator-masked, randomised trial. The Lancet Diabetes & Endocrinology, 6(12), 954–965. https://doi.org/10.1016/S2213-8587(18)30038-X
Desvarieux, M., Demmer, R. T., Jacobs, D. R., et al. (2010). Periodontal bacteria and hypertension: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Journal of Hypertension, 28(7), 1413–1421. https://doi.org/10.1097/HJH.0b013e328338cd36
Dongari-Bagtzoglou, A. (2004). Drug-induced gingival overgrowth. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 98(4), 419–429. https://doi.org/10.1016/0030-4220(93)90027-2
Fisher, M. A., & Taylor, G. W. (2009). A prediction model for the relationship between periodontal disease and untreated hypertension. Journal of Clinical Periodontology, 36(4), 283–289. https://doi.org/10.1902/jop.2009.080226
Graziani, F., Gennai, S., Solini, A., & Petrini, M. (2018). A systematic review and meta-analysis of epidemiologic observational evidence on the effect of periodontitis on diabetes. Journal of Clinical Periodontology, 45(7), 700–712. https://doi.org/10.1111/jcpe.12837
Holmlund, A., Holm, G., & Lind, L. (2006). Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. Journal of Periodontology, 77(7), 1173–1178. https://doi.org/10.1111/jcpe.12837
Miller, C. S., Guggenheimer, J., & Moore, P. A. (2014). Hypertension-related adverse events after dental anesthesia: A review. Anesthesia Progress, 61(2), 65–73.
Tonetti, M. S., & Van Dyke, T. E. (2013). Periodontitis and atherosclerotic cardiovascular disease: Consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. Journal of Periodontology, 84(4-s), S24–S29. https://doi.org/10.1902/jop.2013.1340019
Tsai, C., Hayes, C., & Taylor, G. W. (2021). Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dentistry and Oral Epidemiology, 30(3), 182–192. https://doi.org/10.1034/j.1600-0528.2002.300304.x
World Health Organization. (2023). Hypertension fact sheet. https://www.who.int/news-room/fact-sheets/detail/hypertension
Zhao, D., Lin, Z., Lu, R., et al. (2020). Association between periodontal disease and hypertension: A systematic review and meta-analysis. Journal of Clinical Hypertension, 22(4), 582–591. https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-024-00583-y